Jazz Pharmaceuticals plc — Director's Dealing 2012

Aug 17, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2012-08-16

Reporting Person: FALBERG KATHRYN E (EVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-16	Ordinary Shares	S	7000	$47.48	Disposed	88782	Direct
2012-08-16	Ordinary Shares	S	53000	$47.57	Disposed	0	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.29 to $47.78, inclusive.

F2: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) or footnote (4) to this Form 4.

F3: Includes 35,000 restricted stock units granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four equal annual installments on the anniversary of the grant date, August 9, 2012.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.35 to $47.75, inclusive.